메뉴 건너뛰기




Volumn 3, Issue SUPPL. 1, 1997, Pages s7-s20

Inducible β-lactamase-mediated resistance to third-generation cephalosporins

Author keywords

Ampc; Cefpirome; Derepression; Induction; lactamase

Indexed keywords


EID: 0002634466     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1997.tb00643.x     Document Type: Article
Times cited : (42)

References (8)
  • 1
    • 0025329374 scopus 로고
    • The emergence of bacterial resistance in hospitals: A need for continuous surveillance
    • Brown EH, Spencer RC, Brown JMC. The emergence of bacterial resistance in hospitals: A need for continuous surveillance. J Hosp Infect 1990; 125 (suppl A): 35-9.
    • (1990) J Hosp Infect , vol.125 , Issue.SUPPL. A , pp. 35-39
    • Brown, E.H.1    Spencer, R.C.2    Brown, J.M.C.3
  • 2
    • 25544461564 scopus 로고
    • Trends in antimicrobial utilization and bacterial resistance: Report of the National Resistance Surveillance Group
    • Ballow CH, Schentag JJ. Trends in antimicrobial utilization and bacterial resistance: Report of the National Resistance Surveillance Group. Diagn Microbiol Infect Dis 1992; 15 (suppl): 37S-42S.
    • (1992) Diagn Microbiol Infect Dis , vol.15 , Issue.SUPPL.
    • Ballow, C.H.1    Schentag, J.J.2
  • 3
    • 0028054242 scopus 로고
    • Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Study on the threat of emerging resistances: Real or perceived?
    • Jones RN, Kehrberg EN, Erwin ME, Anderson SC, and the Fluoroquinolone Resistance Surveillance Group. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. Study on the threat of emerging resistances: Real or perceived? Diagn Microbiol Infect Dis 1994; 19: 203-15.
    • (1994) Diagn Microbiol Infect Dis , vol.19 , pp. 203-215
    • Jones, R.N.1    Kehrberg, E.N.2    Erwin, M.E.3    Anderson, S.C.4
  • 4
    • 0028883511 scopus 로고
    • β-lactamases in laboratory and clinical resistance
    • Livermore DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
    • (1995) Clin Microbiol Rev , vol.8 , pp. 557-584
    • Livermore, D.M.1
  • 7
    • 0021335528 scopus 로고
    • Inducible β-lactamase and non-hydrolytic resistance mechanisms
    • Sanders CC. Inducible β-lactamase and non-hydrolytic resistance mechanisms. J Antimicrob Chemother 1984; 13: 1-3.
    • (1984) J Antimicrob Chemother , vol.13 , pp. 1-3
    • Sanders, C.C.1
  • 8
    • 0024042861 scopus 로고
    • Clinical and epidemiological implications for use of newer cephalosporins
    • Sanders CC, Sanders WE Jr. Clinical and epidemiological implications for use of newer cephalosporins. Rev Infect Dis 1988; 10: 830-6.
    • (1988) Rev Infect Dis , vol.10 , pp. 830-836
    • Sanders, C.C.1    Sanders Jr., W.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.